GLP-1 Drugs Are Moving Far Beyond Weight Loss — and Rewriting Chronic Disease Treatment
Health

GLP-1 Drugs Are Moving Far Beyond Weight Loss — and Rewriting Chronic Disease Treatment

New trial data link semaglutide and tirzepatide to improvements in sleep apnea, kidney, liver and heart outcomes, recast...

Noa Feldman 👁 46 💬 0
A Patient's Guide to GLP-1 Side Effects: From GI Upset to Rare Eye Risks
Health

A Patient's Guide to GLP-1 Side Effects: From GI Upset to Rare Eye Risks

GLP-1 drugs are widely prescribed, but patients should understand the range of reported side effects — from common nause...

Noa Feldman 👁 42 💬 0
Trial Finds Ozempic, Wegovy Drug Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder
Health

Trial Finds Ozempic, Wegovy Drug Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder

A 50-patient University of Colorado trial found oral semaglutide reduced heavy drinking and cravings, a step toward the ...

Noa Feldman 👁 44 💬 0
Anvisa Approves Five New Semaglutide Pens, Heating Up Brazil's R$5.6 Billion Weight-Loss Drug War
Companies

Anvisa Approves Five New Semaglutide Pens, Heating Up Brazil's R$5.6 Billion Weight-Loss Drug War

Brazil's health regulator cleared five additional semaglutide pens from Sandoz, Sun Pharma, Ranbaxy, and Brainfarma, sha...

Declan Byrne 👁 55 💬 0